Feed Category: Vaccines & Cell Therapy

Sorrento Therapeutics, Inc.SAN DIEGO, Jan. 29, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a “Frequently Asked Questions” document under the “Investors”… [Read More]

Sorrento Therapeutics, Inc.PALO ALTO, Calif., Jan. 29, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc. (Nasdaq: SRNE,… [Read More]

Though Novavax, Inc. NVAX is one of a handful of vaccine makers that has secured authorizations for its protein-based COVID-19 vaccine in the United States,… [Read More]

Gaithersburg’s Novavax ‘prepared to deliver’ updated Covid-19 vaccine following FDA advisory panel voteIn this article: Oops!Something went wrong.Please try again later.An FDA advisory committee voted… [Read More]

Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna SlipIn this article: Oops!Something went wrong.Please try again later.Oops!Something went wrong.Please try again later.Oops!Something… [Read More]

Three Motley Fool contributors were asked to identify great growth stocks down 20% or more to buy now. Here’s why they chose Beam Therapeutics (NASDAQ:… [Read More]

On Jan 26, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously recommended moving toward a uniform vaccine strain composition for all COVID-19… [Read More]

In the latest trading session, Novavax (NVAX) closed at $10.98, marking a -1.17% move from the previous day. This change lagged the S&P 500’s 1.1%… [Read More]

New Novavax CEO John Jacobs Takes The Helm — But Is NVAX Stock A Buy Today?In this article: Oops!Something went wrong.Please try again later.Is Novavax… [Read More]

By Leroy LeoJan 26 (Reuters) – Novavax Inc said on Thursday it would require six months to produce a COVID-19 vaccine designed to match whichever… [Read More]

Shares of Dynavax Technologies (DVAX) have gained 15% over the past four weeks to close the last trading session at $11.81, but there could still… [Read More]

Though Novavax, Inc. NVAX is one of a handful of vaccine makers that has secured authorizations for its protein-based COVID-19 vaccine in the United States,… [Read More]